Market Size (2025)
$894.85M
Vertical: CNMBase Year: 2025
Market Size (2025)
$894.85M
Projected (2032)
$1.75B
CAGR (2022–2032)
10.1%
Key Players
10+
Market Overview
The Global Mycorrhizal Inoculants Market was valued at USD 894.9 Million in 2025 and is projected to reach USD 1,750.8 Million by 2032, registering a CAGR of 10.05% during 2026–2032. The market has expanded steadily from USD 668.5 Million in 2022, and the forecast period adds an absolute opportunity of USD 855.9 Million between 2025 and 2032. Mycorrhizal inoculants are biological products containing propagules of symbiotic fungi that colonise plant roots and extend the effective root system, improving the uptake of phosphorus, micronutrients and water. They are applied as seed treatments, in-furrow, through irrigation and fertigation systems, at transplanting and as components of growing media.
Demand is supported by the search for higher nutrient-use efficiency in crop production, policy programmes in Europe, India and Latin America that seek to reduce dependence on synthetic fertilisers, the expansion of organic and regenerative farming, and the use of mycorrhizae in horticulture, landscaping, turf and reforestation. The market is moving from a horticulture-centred niche towards broad-acre row crops, where low-dose seed-applied and liquid formulations have made per-hectare treatment costs more competitive.
Key Findings
By mycorrhiza type: Arbuscular (Endo) is the largest segment with a 75.00% share in 2025 (USD 671.1 Million) and is also the fastest-growing segment, at a CAGR of 10.55%. Ecto & Others accounts for 25.00% and grows at 8.44%.
By physical form: Powder & Granules leads with a 70.00% share (USD 626.4 Million), while Liquid is the fastest-growing form at a CAGR of 11.75%.
By crop type: Fruits & Vegetables is the largest segment with a 45.00% share (USD 402.7 Million), whereas Cereals & Grains is the fastest-growing segment at a CAGR of 12.12%.
By region: North America is the leading region with a 32.00% share (USD 286.4 Million) in 2025. Asia Pacific is the fastest-growing region, at a CAGR of 12.52%, rising from USD 179.0 Million in 2025 to USD 409.7 Million by 2032.
By country: The U.S. is the largest country market at USD 234.8 Million in 2025, and India is the fastest-growing country, at a CAGR of 14.93% over 2026–2032.
Segmentation Summary
The market is analysed by mycorrhiza type (Arbuscular (Endo); Ecto & Others), physical form (Powder & Granules; Liquid), crop type (Fruits & Vegetables; Cereals & Grains; Turf & Forestry & Others) and region (North America, Europe, Asia Pacific, Latin America, and Middle East & Africa), with country-level coverage within each region. Table 1.1 summarises the largest and fastest-growing segment in each segmentation.
Competitive Landscape Summary
The competitive landscape is moderately fragmented. A small group of companies with in-house production of mycorrhizal propagules at industrial scale, notably Premier Tech, Sumitomo Biorational Company (Valent BioSciences and its subsidiary Mycorrhizal Applications), Corteva Agriscience (through Symborg) and Koppert, compete alongside specialist producers such as Groundwork BioAg, Atens, INOQ and Lallemand Plant Care, and regional suppliers such as T. Stanes & Company and UPL (through its NPP biosolutions unit) in India. Recent activity has centred on acquisitions by agrochemical majors, new production capacity, distribution and private-label partnerships, and portfolio rebranding.
Challenges and Opportunities
The principal challenges are the variability of field responses under differing soil phosphorus levels, native fungal populations and tillage practices; uneven product quality across suppliers; and the cost and time of producing obligate symbionts that cannot be grown on conventional fermentation media. Fragmented registration requirements across countries also lengthen market entry. Opportunities arise from low-dose seed-treatment and liquid formats for row crops, blending of mycorrhizae into fertiliser granules and growing media, integration with soil-carbon programmes, and rapid adoption in India, Brazil and other emerging agricultural economies.
Future Outlook
Between 2025 and 2032 the market is expected to nearly double, from USD 894.9 Million to USD 1,750.8 Million. Growth is expected to be led by arbuscular products for broad-acre crops, liquid formulations compatible with seed-treatment and fertigation equipment, and the Asia Pacific, Latin America and Middle East & Africa regions, whose growth rates exceed those of the mature North American and European markets. Suppliers that can demonstrate consistent agronomic return, secure regulatory approvals in multiple jurisdictions and access the distribution networks of large crop-input companies are expected to gain share.
The Mycorrhizal Inoculants Market market is projected to grow at a CAGR of 10.1% from 2022 to 2032.
Subscribe to Wantstats
Unlock premium reports, insights, blogs, charts and more.
View Subscription PlansSubscribe to Wantstats
Unlock premium reports, insights, blogs, charts and more.
View Subscription PlansDefinition
Mycorrhizal inoculants are formulated products containing viable propagules (spores, hyphal fragments and colonised root pieces) of mycorrhizal fungi, intended to establish or reinforce the symbiotic association between these fungi and plant roots. In the symbiosis, the plant supplies the fungus with carbon, while the fungal hyphal network extends beyond the root depletion zone and transfers phosphorus, nitrogen, zinc, copper and water to the host. Additional effects include improved soil aggregation, greater tolerance to drought and salinity stress and better transplant survival.
Arbuscular (endo) mycorrhizal fungi belong to the phylum Glomeromycota (for example Rhizophagus irregularis, formerly Glomus intraradices, and Funneliformis mosseae). They penetrate root cortical cells and form arbuscules, and they associate with most agricultural and horticultural crops. Ectomycorrhizal fungi (for example Pisolithus, Rhizopogon, Laccaria and Scleroderma species) form a sheath around the root and an intercellular Hartig net, and are associated mainly with forest trees such as pines, oaks, eucalyptus and birch. The "Others" category includes ericoid and orchid mycorrhizae and blended endo-ecto products.
Included in the scope: single-species and multi-species mycorrhizal inoculants, mycorrhiza-based consortia in which mycorrhizal fungi are a declared active component, and inoculants supplied as powders, granules, tablets, root-dip gels and liquid suspension concentrates for agriculture, horticulture, turf, landscaping, forestry and land reclamation. Excluded from the scope: inoculants based only on bacteria (such as Rhizobium, Azospirillum, Azotobacter or Bacillus), Trichoderma-only products, phosphate-solubilising Penicillium products, signal-molecule products that stimulate native mycorrhizal colonisation without containing fungal propagules, and growing media or fertilisers in which mycorrhizae are not a declared component. The value of growing media, fertilisers or seeds into which inoculants are incorporated is not counted; only the value of the inoculant is considered.
Scope of the Study
The study covers the global market for mycorrhizal inoculants, segmented as given below. Market values are presented in USD Million for the historic years 2022, 2023 and 2024, the base year 2025 and the forecast years 2026–2032, with the compound annual growth rate calculated for 2026–2032.
Research Objectives
To estimate the size of the global mycorrhizal inoculants market for 2022–2025 and forecast it for 2026–2032 in USD Million.
To analyse the market by mycorrhiza type, physical form and crop type, and to identify the largest and fastest-growing segments.
To assess regional and country-level demand across North America, Europe, Asia Pacific, Latin America and Middle East & Africa.
To evaluate the drivers, restraints, opportunities and challenges affecting the adoption of mycorrhizal inoculants in agriculture, horticulture, turf and forestry.
To examine the value chain, from propagule production through formulation and distribution to end users, and the competitive forces acting on suppliers.
To review the regulatory frameworks that govern the registration, labelling and quality of mycorrhizal products in key markets.
To identify the leading suppliers, their positioning and their strategic developments since 2022.
To outline growth opportunities in emerging formats such as seed-applied, liquid and fertiliser-blended inoculants.
Subscribe to Wantstats
Unlock premium reports, insights, blogs, charts and more.
View Subscription PlansSubscribe to Wantstats
Unlock premium reports, insights, blogs, charts and more.
View Subscription PlansSubscribe to Wantstats
Unlock premium reports, insights, blogs, charts and more.
View Subscription PlansOverview of the Research Process
The study followed a structured process combining secondary research, primary research, market size estimation and forecasting, and validation. The process moved through five stages: (1) definition of the market scope and segmentation; (2) collection of secondary data on production, trade, crop area, agricultural input use, regulations and company activity; (3) primary consultations with participants across the value chain to validate assumptions and fill information gaps; (4) estimation of the market size through top-down and bottom-up approaches, reconciled through data triangulation; and (5) forecasting of the market to 2032 on the basis of identified growth factors, followed by internal review for consistency across segments, regions and countries.
Secondary Research
Secondary research established the baseline understanding of the market, its participants and its demand drivers. The sources consulted included:
Industry associations: bodies representing biostimulant, biological-input and fertiliser manufacturers, such as the European Biostimulants Industry Council (EBIC), the Biological Products Industry Alliance (BPIA), the International Biocontrol Manufacturers Association (IBMA), the Association of American Plant Food Control Officials (AAPFCO) and national biological-input associations in India and Brazil.
Government and regulatory bodies: agriculture ministries and regulators, including the United States Department of Agriculture, the Canadian Food Inspection Agency, the European Commission, India's Ministry of Agriculture & Farmers Welfare and the National Centre of Organic and Natural Farming, Brazil's Ministry of Agriculture and Livestock (MAPA), and China's Ministry of Agriculture and Rural Affairs, for registration data, crop-area statistics and policy documents.
Company filings and publications: annual reports, investor presentations, press releases, product labels and technical bulletins of mycorrhizal inoculant producers and agricultural input companies.
Trade journals and scientific literature: agricultural and horticultural trade publications, and peer-reviewed research on mycorrhizal efficacy, production technologies and product quality.
Paid databases: company financial databases, trade statistics and agricultural market databases used to profile suppliers and cross-check crop-area and input-use data.
Primary Research
Primary research was conducted through in-depth telephone and online interviews with participants on the supply and demand sides of the market. The objectives were to validate the market definition and segmentation, verify estimates of market size and segment splits, understand pricing, application rates and adoption barriers, and obtain views on the future direction of the market.
Supply-side respondents: senior executives, product managers, R&D and regulatory specialists, and sales managers at mycorrhizal inoculant manufacturers, biological-input formulators, growing-media producers and distributors.
Demand-side respondents: agronomists, crop advisers, commercial growers of fruits and vegetables and field crops, nursery and greenhouse operators, turf and landscape managers, forestry nursery managers, and researchers at agricultural universities and institutes.
Market Size Estimation
Top-down approach: the market was derived from the wider agricultural biologicals and biofertiliser market, with the share attributable to mycorrhizal inoculants estimated from company revenues, product portfolios and expert inputs. This value was then allocated to segments, regions and countries using adoption rates, crop area and regional input-use patterns.
Bottom-up approach: the market was built up from the revenues of identified suppliers of mycorrhizal inoculants and from demand-side estimates of treated area by crop and region, multiplied by typical application rates and average selling prices per hectare or per unit of product.
Data triangulation: the results of the two approaches were compared and reconciled. Differences were resolved by reviewing assumptions with primary respondents and by cross-checking against secondary data, so that segment, regional and country estimates are consistent with the overall market total.
Forecasting Methodology
The forecast was developed by projecting the base-year market through 2032 using a combination of trend analysis and factor-based adjustments. The factors considered included crop area and cropping patterns, fertiliser prices and phosphorus availability, policy targets for fertiliser reduction and organic farming, adoption rates of biological inputs by crop and region, product innovation and formulation trends, pricing trends, regulatory developments and macroeconomic conditions in agriculture. Growth rates were set separately for each segment, region and country and then reconciled with the overall market forecast.
Assumptions and Limitations
Market values represent revenues at the manufacturer and first-seller level for mycorrhizal inoculant products and exclude the value of the carrier products into which they are incorporated.
Values for all years are expressed in nominal USD; exchange-rate movements are not separately modelled for the forecast period.
The forecast assumes no major disruption to agricultural production, trade or regulatory regimes beyond developments known at the time of the study.
Revenues of diversified companies attributable to mycorrhizal products are estimated where they are not separately disclosed.
Combined products (for example mycorrhiza-bacteria consortia) are included where mycorrhizal fungi are a declared active component.
Country-level estimates for "Rest of" categories are aggregates of multiple markets and may conceal differences between individual countries.
Base Year
2025
Historical Period
2022 – 2024
Forecast Period
2026 – 2032
Primary Interviews
150+
Historical data (2022–2025) and forecast period (2025–2032)
Our research process spans primary interviews with industry stakeholders combined with comprehensive secondary data analysis, validated through triangulation across multiple independent sources.
Subscribe to Wantstats
Unlock premium reports, insights, blogs, charts and more.
View Subscription PlansIntroduction
The Global Mycorrhizal Inoculants Market is moderately fragmented. A limited number of companies combine proprietary fungal strains, industrial-scale propagule production and international distribution, while a larger group of specialist and regional producers compete in particular crops, application segments or countries. Because arbuscular mycorrhizal fungi must be produced on living host plants or in root-organ culture, production capability and quality assurance are important sources of competitive advantage. Many products are based on similar species, so suppliers differentiate through propagule concentration, formulation, strain selection, agronomic trial data and channel access.
Competition has intensified since 2022 as major crop-input companies have entered or expanded in the market through acquisitions and partnerships. Corteva Agriscience acquired Symborg in 2023, Sumitomo Chemical consolidated its biorational businesses, including Valent BioSciences and its subsidiary Mycorrhizal Applications, into Sumitomo Biorational Company in 2026, and ADAMA and Syngenta have entered distribution and private-label agreements with Groundwork BioAg. Specialist producers are responding by expanding capacity, launching crop-specific products, consolidating brands and building partnerships with distributors.
Key Player Positioning
Leaders: Premier Tech, Sumitomo Biorational Company (Valent BioSciences and Mycorrhizal Applications) and Corteva Agriscience (through Symborg) combine broad mycorrhizal portfolios, large-scale production and extensive distribution. Premier Tech has produced endomycorrhizal inoculum industrially since 2000 and markets its technology through the AGTIV brand and PRO-MIX growing media. Sumitomo Biorational Company markets the MycoApply range across horticulture, turf and row crops and is building a new manufacturing facility for arbuscular mycorrhizal fungi in Oregon. Corteva sells the Glomus iranicum-based MycoUp and Resid lines through its global crop protection channel.
Challengers: Groundwork BioAg, Koppert and Lallemand Plant Care are expanding their presence. Groundwork BioAg focuses on high-concentration inoculants for broad-acre crops and has built a partner network that includes ADAMA and Syngenta. Koppert, a leader in biological control, is scaling mycorrhiza production in India and selling mycorrhiza-based blends in Europe. Lallemand Plant Care leverages its microbial fermentation expertise and global footprint to market the LALRISE range.
Niche and regional players: Atens and INOQ are specialist mycorrhiza producers with strong technical credentials in Europe, the former with large in vivo production capacity and crop-specific products for horticulture and vineyards, the latter with products for agriculture, horticulture, turf and forestry. T. Stanes & Company and UPL, through its NPP biosolutions unit, supply mycorrhizal biofertilisers primarily in India.
Threat of New Entrants – Medium
Production of arbuscular propagules at consistent quality requires specialised know-how, proprietary strains and capital investment, which raises entry barriers.
Registration costs and data requirements under frameworks such as the EU Fertilising Products Regulation and national biofertiliser rules add time and expense for new entrants.
However, small regional producers can enter local markets with simpler in vivo production, and venture funding continues to support agricultural biological start-ups.
Bargaining Power of Suppliers – Low
Substrates, carriers and packaging materials are widely available commodities with many alternative sources.
The most valuable input, fungal strains, is generally developed and owned in-house by producers.
Equipment for greenhouse and in vitro production is not highly specialised to a few vendors.
Bargaining Power of Buyers – Medium
Large distributors and agrochemical partners that control access to growers can negotiate favourable private-label and supply terms.
Growers can choose among several brands and can forgo inoculation where returns are uncertain.
Individual farmers and nurseries are fragmented buyers with limited negotiating power, and differentiated products with proven efficacy retain pricing power.
Threat of Substitutes – Medium
Conventional phosphate fertilisers remain the primary means of supplying phosphorus and are widely available.
Phosphate-solubilising microbes, bacterial biofertilisers, biostimulant extracts and signal-molecule products compete for the same nutrient-efficiency budget.
Mycorrhizae offer distinct benefits in water uptake, soil structure and transplant establishment that substitutes do not fully replicate.
Intensity of Competitive Rivalry – High
Numerous global, regional and local suppliers compete, and many products are based on similar species such as Rhizophagus irregularis.
Competitors differentiate on propagule concentration, formulation, strain selection and agronomic evidence, and invest in rebranding and new launches.
Acquisitions by crop-input majors and their strong channel access intensify competition for specialist producers.
Threat of New Entrants: Medium; Technical and regulatory barriers offset by low-cost regional entry.
Bargaining Power of Suppliers: Low; Commodity inputs; strains held in-house.
Bargaining Power of Buyers: Medium; Concentrated distributors versus fragmented growers.
Threat of Substitutes: Medium; Phosphate fertilisers and other biologicals compete for spend.
Intensity of Competitive Rivalry: High; Many suppliers with similar species; active M&A and launches.
Market estimates by geography (2032)
InsightNorth America leads with $516.47M by 2032, while Asia Pacific is projected to grow fastest at a 12.7% CAGR.
Subscribe to Wantstats
Unlock premium reports, insights, blogs, charts and more.
View Subscription Plans| REGION | 2022 | 2025 | 2032 | CAGR | SHARE |
|---|---|---|---|---|---|
| North America | $220.61M | $339.87M | $516.47M | 8.9% | 30% |
| Europe | $209.91M | $316.86M | $483.21M | 8.7% | 28% |
| Asia Pacific | $124.34M | $227.44M | $409.68M | 12.7% | 23% |
| Latin America | $94.93M | $167.43M | $281.87M | 11.5% | 16% |
| Middle East & Africa | $18.72M | $33.91M | $59.53M | 12.3% | 3% |
| Total | $668.50M | $1.09B | $1.75B | 10.1% | 100% |
Subscribe to Wantstats
Unlock premium reports, insights, blogs, charts and more.
View Subscription PlansTotal Market Size
$1.75B
| APPLICATION | REVENUE ($B) | GROWTH RATE | MARKET PENETRATION |
|---|---|---|---|
| Arbuscular (Endo) | $1.36B | 10.7% | 78% |
| Ecto & Others | $393.92M | 8.4% | 23% |
* Revenue projections based on 2025 estimates. Growth rates represent CAGR 2024–2030. Market penetration indicates current adoption rate within addressable market segments.
Subscribe to Wantstats
Unlock premium reports, insights, blogs, charts and more.
View Subscription PlansSee plans for professionals or small and medium businesses.

Analytical insights on Mycorrhizal Inoculants Market covering market dynamics, competitive landscape, and strategic outlook.
The Mycorrhizal Inoculants Market market is projected to reach $1.75B by 2032, growing at 10.1% CAGR. The Arbuscular (Endo) segment holds the largest share.
The Global Mycorrhizal Inoculants Market is shaped by a combination of agronomic, economic, regulatory and environmental factors. On the demand side, growers are seeking ways to maintain yields while using fertiliser more efficiently, and governments are setting targets to reduce nutrient losses and expand organic and natural farming. On the supply side, advances in propagule production and formulation have lowered treatment costs and enabled new application methods. Against this, inconsistent field performance, product-quality concerns and fragmented regulation continue to slow adoption in some crops and regions.
Section 4.2 sets out the relative influence of ten macro and micro factors on the market over three forecast windows. The impact scores, on a scale of 1 to 10, are analyst assessments based on the secondary and primary research conducted for this study; a higher score indicates a stronger influence in the stated direction.
Need for Higher Phosphorus- and Nutrient-Use Efficiency
Phosphorus is one of the least efficiently used crop nutrients: a large part of applied phosphate binds to soil minerals and becomes unavailable to plants, and phosphate rock is a finite resource concentrated in a small number of producing countries. The sharp rise in fertiliser prices in 2021–2022, following supply disruptions and export restrictions, exposed growers to cost volatility and renewed interest in inputs that improve nutrient recovery. Mycorrhizal hyphae explore a far larger soil volume than roots alone and can access phosphate beyond the root depletion zone, which allows growers to maintain yields at lower application rates or to obtain greater return from existing applications. Seed-company and agrochemical partners increasingly position mycorrhizal inoculants within nutrient-efficiency programmes for maize, soybean, wheat and vegetables, and the growth of the Cereals & Grains segment, at a CAGR of 12.12%, reflects this shift towards broad-acre use. As long as fertiliser markets remain exposed to supply shocks, efficiency-enhancing biologicals are expected to remain a priority for growers and distributors.
Policy Support for Reduced Chemical Inputs and Biological Agriculture
Public policy in several major agricultural regions is supporting the substitution of part of the synthetic fertiliser load with biological inputs. In the European Union, the Farm to Fork Strategy set targets to reduce nutrient losses by at least 50% and fertiliser use by at least 20% by 2030, and to bring 25% of agricultural land under organic farming; the EU Fertilising Products Regulation (EU) 2019/1009, applicable since July 2022, explicitly allows mycorrhizal fungi as a component of CE-marked microbial plant biostimulants. In India, the Fertiliser (Control) Order includes mycorrhizal biofertilisers among its notified biofertilisers, the PM-PRANAM scheme approved in 2023 rewards states that reduce chemical fertiliser consumption, and the National Mission on Natural Farming approved in 2024 promotes chemical-free cultivation. Brazil launched a National Bioinputs Programme in 2020 and enacted a dedicated bioinputs law (Law No. 15,070) in December 2024. These measures create registration pathways, demonstration programmes and incentives that favour adoption of mycorrhizal products.
Growth of Organic, Regenerative and High-Value Horticulture
Organic production standards restrict the use of soluble synthetic fertilisers, making biological nutrition aids such as mycorrhizal inoculants a natural fit; many commercial products are listed for organic use by certifying and input-review organisations. At the same time, food companies and retailers have made regenerative-agriculture sourcing commitments that emphasise soil health, which has led to grower programmes including biological inputs. High-value horticulture is the largest application area, with Fruits & Vegetables accounting for 45.00% of the market in 2025. Growers of transplanted vegetables, berries, vines and orchards use mycorrhizae to improve establishment and root development, and greenhouse growers rely on growing media pre-blended with inoculants. Leading growing-media producers, including Premier Tech with its PRO-MIX range, market mycorrhiza-containing media to professional growers, which embeds inoculants into routine production practice. Nurseries producing fruit trees, vines and ornamentals apply mycorrhizae at potting to obtain more uniform plants, while landscapers and garden-centre customers increasingly purchase inoculants for planting. As certified organic area and premium produce segments expand, these established horticultural uses provide a stable base of demand for suppliers.
Climate Resilience, Soil Health and Carbon Programmes
More frequent droughts, heat waves and soil degradation are raising grower interest in inputs that improve water uptake and stress tolerance. Mycorrhizal associations improve plant water relations and contribute to soil aggregation, and these benefits are increasingly cited in soil-health programmes. Soil-carbon markets have added a new dimension: Groundwork BioAg launched its Rootella Carbon programme in 2023, signed an agreement in 2025 to market carbon removal credits, and in June 2026 announced the first credits issued under the Verra VM0042 methodology for its programme. Mycorrhizae are also used in reforestation, mine-site rehabilitation and landscape restoration, where ectomycorrhizal inoculation of nursery seedlings improves field survival. These uses broaden the customer base beyond conventional agriculture and support demand in the Turf & Forestry & Others segment. Water scarcity is particularly relevant in Middle East & Africa, Latin America and parts of Asia Pacific, where irrigated horticulture depends on efficient use of limited water, and these regions are growing faster than the global average. Climate-adaptation programmes and soil-health initiatives are therefore expected to remain a lasting source of demand.
Seed-Applied and Liquid Formulations for Row Crops
High-concentration formulations that can be applied as seed treatments or in-furrow through existing planter equipment reduce the cost per hectare and fit row-crop workflows. Products such as Groundwork BioAg's Rootella range, Sumitomo Biorational Company's MycoApply EndoFuse and EndoMaxx SC, and Lallemand Plant Care's LALRISE PRIME target this opportunity. The Liquid segment is projected to grow from USD 268.5 Million in 2025 to USD 586.5 Million by 2032, the highest growth among physical forms.
Integration into Fertiliser Blends and Growing Media
Combining mycorrhizal inoculants with fertiliser granules, starter fertilisers and growing media allows growers to apply them without an additional field operation. In June 2026, Corteva Agriscience received French approval for RESID G, described by the company as the first granular mycorrhiza formulation approved for blending into fertilisers for field crops. Similar co-formulation with fertiliser manufacturers and blenders offers suppliers access to large existing distribution volumes.
Rapid Adoption in Emerging Agricultural Economies
Asia Pacific, Latin America and Middle East & Africa are growing faster than the global average, at CAGRs of 12.52%, 11.08% and 11.98% respectively. India's support for biofertilisers and natural farming, Brazil's well-developed inoculant culture in soybean and its new bioinputs law, and investment in high-value horticulture and landscaping in the Gulf countries create favourable conditions. Local production capacity, such as Koppert's mycorrhiza production facility in Hyderabad inaugurated in 2026, is improving supply in these regions.
Inconsistent Field Performance
The response of crops to mycorrhizal inoculation depends on soil phosphorus levels, the presence of competitive native fungi, tillage, crop rotation, fungicide use and the compatibility between fungal strain and host plant. In soils with high available phosphorus or in non-mycorrhizal crops such as brassicas and sugar beet, benefits can be small or absent. Because yield responses vary from field to field and season to season, many growers remain uncertain of the return on investment, and distributors must invest in trials and agronomic support to build confidence. This variability is the most frequently cited barrier to adoption in broad-acre crops.
Product Quality and Production Constraints
Arbuscular mycorrhizal fungi are obligate symbionts that cannot be cultured without a living host, so propagules must be produced on host plants in substrate or in root-organ culture systems. Production is slower and more capital-intensive than bacterial fermentation, and maintaining viability and purity through formulation, storage and distribution is demanding. Independent evaluations published in the scientific literature have found that a significant share of commercial inoculants tested did not colonise roots as claimed, which has affected market credibility and prompted calls for stricter quality standards. Smaller suppliers without strong quality-control systems face increasing scrutiny as regulations tighten.
Fragmented and Evolving Regulation
Mycorrhizal inoculants are classified differently across jurisdictions: as biofertilisers, soil amendments, plant biostimulants or supplements. Registration requirements, efficacy data and labelling rules vary between countries and, in the United States, between states. Multi-country registration is costly and time-consuming, particularly for small and mid-sized specialist producers, and delays in implementing new frameworks can slow product launches.
Challenge: Demonstrating Return on Investment
Suppliers must prove consistent economic benefit across diverse soils and management systems. This requires multi-season trial networks, diagnostic tools for assessing native mycorrhizal populations and colonisation, and recommendations that identify where inoculation is most likely to pay. Companies investing in agronomic data and digital decision-support are better positioned to convert trial results into repeat purchases.
Challenge: Compatibility with Conventional Inputs
Mycorrhizal propagules can be affected by some fungicide seed treatments, high rates of soluble phosphate and certain soil-applied pesticides. Ensuring compatibility with the chemical treatments that growers already use, and providing clear guidance on tank-mixing and seed-treatment sequencing, is an ongoing technical and commercial challenge.
Trend: Consolidation and Partnerships with Crop-Input Majors
Large crop-input companies are building biological portfolios through acquisitions and partnerships. Corteva Agriscience completed its acquisition of Symborg, whose portfolio includes the MycoUp and Resid mycorrhizal lines, in March 2023. Groundwork BioAg partnered with ADAMA in India (2022) and China (2025) and in July 2026 entered a partnership under which Syngenta will sell its mycorrhizal products under the Syngenta label in Latin America and Europe. Sumitomo Chemical combined Valent BioSciences, MGK and Valent North America into Sumitomo Biorational Company in 2026.
Trend: Multi-Strain Consortia and Brand Consolidation
Suppliers are combining mycorrhizal fungi with beneficial bacteria and Trichoderma to offer broader root-health benefits, and are consolidating product lines under single biological brands. Premier Tech brought its MYKE PRO and PRO-MIX mycorrhizal products under its AGTIV brand in 2024–2025, and Koppert markets mycorrhiza-bacteria blends under its Vici brand in Europe.
The value chain of mycorrhizal inoculants comprises four main stages, from the sourcing of biological and physical inputs to the application of products by end users.
Raw materials and inputs: The key input is the fungal strain itself; producers maintain proprietary strain collections and select isolates for colonisation ability, host range and stress tolerance. Physical inputs are generally commodity materials, but substrate purity is critical to avoid contamination.
Production and formulation: This stage captures the largest share of value. Because arbuscular fungi require a living host, production scale, cycle time and quality assurance determine cost competitiveness. Formulation determines the application method, shelf life and compatibility with equipment.
Distribution: Access to growers is often controlled by large crop-input companies and distributors, which explains the importance of licensing, private-label and distribution partnerships. Incorporation into growing media and fertilisers offers an indirect route to market.
End users: Purchase decisions depend on crop value, perceived return, agronomic advice and compatibility with existing practices. High-value horticulture and professional nurseries are early adopters, while broad-acre farmers are the main source of future volume growth.
Across regions, regulation is moving towards clearer definitions of biostimulants and microbial products, minimum quality standards for viable propagules and stricter controls on label claims. The expansion of the list of permitted microorganisms under the EU Fertilising Products Regulation and the implementing rules for Brazil's Bioinputs Law are the main developments to monitor during the forecast period.
Feb 2022: Groundwork BioAg; Expansion; Expanded its mycorrhizal inoculant business in Brazil with distributor NovaTero.
Jun 2022: Groundwork BioAg; ADAMA; Partnership; Commercial agreement with ADAMA India to offer the Tormos mycorrhizal inoculant to Indian farmers.
Jun 2022: Valent BioSciences; Expansion; Announced a major expansion of its fermentation manufacturing plant in Osage, Iowa.
Jul 2022: Groundwork BioAg; Investment; Acquired a stake in NovaTero BioAg, its exclusive distributor in Brazil.
Jul 2022: Premier Tech; Product Launch; Repositioned its AGTIV inoculant offer for agriculture, including AGTIV REACH (mycorrhizae) and AGTIV THRIVE (mycorrhizae plus rhizobium).
Aug 2022: Groundwork BioAg; Investment; Raised USD 18 million in Series B funding led by Climate Innovation Capital.
Aug 2022: Valent BioSciences; Expansion; Expanded arbuscular mycorrhizal fungi research, including in vitro work at the Danforth Center and laboratory space at Mycorrhizal Applications in Grants Pass, Oregon.
Sep 2022: Corteva Agriscience; Acquisition; Signed an agreement to acquire Symborg, a Spanish biologicals company with mycorrhizal products.
Mar 2023: Corteva Agriscience; Acquisition; Completed the acquisitions of Symborg and Stoller.
Sep 2023: Valent BioSciences; Expansion; Began construction of a new arbuscular mycorrhizal fungi manufacturing facility in White City, Oregon, to meet demand for MycoApply products.
Oct 2023: Groundwork BioAg; Product Launch; Launched the Rootella Carbon soil-carbon programme.
Nov 2023: Lallemand Plant Care; Partnership; Exclusive partnership with New Edge Microbials to bring Lallemand biological products to Australia.
Dec 2023: Groundwork BioAg; Expansion; Rootella approved for commercialisation in China, Argentina and South Africa.
Feb 2024: Koppert; Investment; Received a EUR 140 million preferred-equity investment from HAL Investments to fund production expansion and growth.
Apr 2024: Atens; Product Launch; Launched Aegis VINE and Asir VINE, mycorrhizal products based on the MV1 strain developed for vineyards.
Jun 2024: Premier Tech; Product Launch; Co-branded PRO-MIX growing media with AGTIV technologies; the mycorrhizal ingredient was renamed AGTIV REACH.
Sep 2024: Lallemand Plant Care; Expansion; Opened new research and development laboratories in Toulouse, France.
Dec 2024: Corteva Agriscience; Product Launch; Introduced the Resid MG mycorrhizal microgranule in Poland for the 2025 season.
Jan 2025: Groundwork BioAg; ADAMA; Partnership; Exclusive agreement for ADAMA to sell Rootella in China from the 2025 season.
Feb 2025: Groundwork BioAg; Product Launch; Expanded the Rootella portfolio, including Rootella Forte, at Commodity Classic 2025.
Mar 2025: Premier Tech; Product Launch; Brought MYKE PRO mycorrhizal products under the AGTIV brand as AGTIV REACH.
Sep 2025: Groundwork BioAg; Partnership; Agreement with Anew Climate to market carbon removal credits generated through Rootella Carbon.
Oct 2025: Sumitomo Chemical; Restructuring; Announced the combination of Valent BioSciences, MGK and Valent North America into Sumitomo Biorational Company, effective April 2026.
Feb 2026: Koppert; Expansion; Inaugurated an expanded mycorrhiza production facility in Hyderabad, India, through Koppert Sustainable Solutions India.
Jun 2026: Corteva Agriscience; Regulatory Approval; Received French approval for RESID G, a granular mycorrhiza formulation for blending into fertilisers for field crops.
Jun 2026: Groundwork BioAg; Other; First Verra-verified carbon credits issued under the Rootella Carbon programme.
Jul 2026: Groundwork BioAg; Syngenta; Partnership; Partnership under which Syngenta will sell Groundwork BioAg mycorrhizal products under the Syngenta label, initially in Latin America and Europe.
Near-term growth will likely concentrate in modular bioreactor lines and closed-system media workflows that shorten validation cycles while preserving batch traceability.
Partnerships between CDMOs and instrumentation vendors should accelerate standard datasets for comparability across sites, improving forecasting models used in capacity planning.
Longer horizon, organoid and microphysiological adoption may reshape segment mix; teams that invest early in assay interoperability and cloud QC hooks are better positioned to capture upside without fragmenting their analytics stack.
Profiles of 107 companies operating in the Mycorrhizal Inoculants Market market, including revenue, employee count, and market positioning where available.
Showing 107 of 107 companies
Company Headquarters: Indianapolis, US Founded: 1989 Workforce: ~21,100 Company Working: Corteva Agriscience develops, manufactures, and markets a wide range of products, including seeds and traits, crop protection, software, and digital solutions, seed treatments, forages, inoculants, vegetation management, pasture management, turf and ornamental, urban pest management, and oil. It is directly present in more than 50 countries and covers all major regions such as North America, Asia-Pacific, Latin America, Europe, and the Middle East & Africa. Corteva Agriscience is a subsidiary of Dow Chemical Company. Hence, the provided financial information is of the Dow Chemical Company.
4 interactive charts drawn from the Mycorrhizal Inoculants Market dataset — market size, regional splits and each segment breakdown. Open one to read its full data table and download it.
Global Mycorrhizal Inoculants Market By Crop Type
Global Mycorrhizal Inoculants Market By Physical Form
Global Mycorrhizal Inoculants Market By Mycorrhiza Type
Global Mycorrhizal Inoculants Market By Region
Powering the world's best teams.
From next-gen startups to established enterprises.
Trusted by forward-thinking businesses
for data-driven intelligence
Historical performance and future projections (2020–2030, USD Billion)
Market Size (USD Million)